We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

200 hedge funds and large institutions have $2.1B invested in Bio-Rad Laboratories Class A in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 79 increasing their positions, 72 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

10% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 72

0.71% more ownership

Funds ownership: 77.69% → 78.4% (+0.71%)

5% less capital invested

Capital invested by funds: $2.2B → $2.1B (-$101M)

9% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 22

2% less funds holding

Funds holding: 204 → 200 (-4)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
200
Holders Change
-4
Holders Change %
-1.96%
% of All Funds
5.8%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
20
Increased
79
Reduced
72
Closed
22
Calls
$1.01M
Puts
–
Net Calls
+$1.01M
Net Calls Change
-$560K

Top Buyers

Rank Fund Capital Flow
1
EIP
Epoch Investment Partners
New York
+$22.3M
2
AI
Ariel Investments
Illinois
+$9.93M
3
LCS
Levin Capital Strategies
New York
+$9.37M
4
TCM
Tamarack Capital Management
California
+$7.94M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$6.9M

Top Sellers

Rank Fund Capital Flow
1
Norges Bank
Norges Bank
Norway
-$18.3M
2
RA
Royce & Associates
New York
-$17.7M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$14.8M
4
CIP
Champlain Investment Partners
Vermont
-$14.6M
5
Wells Fargo
Wells Fargo
California
-$10.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
SAM
26
Sentinel Asset Management
Vermont
$20.8M +$6.38M +53,850 +41%
PAMP
27
Polar Asset Management Partners
Ontario, Canada
$20.3M – – –
ICOM
28
Investment Counselors of Maryland
Maryland
$19.7M -$521K -4,399 -2%
EARNEST Partners
29
EARNEST Partners
Georgia
$19M -$545K -4,599 -3%
Charles Schwab
30
Charles Schwab
California
$18.6M +$1.15M +9,726 +6%
Norges Bank
31
Norges Bank
Norway
$17.5M -$18.3M -154,412 -50%
Dimensional Fund Advisors
32
Dimensional Fund Advisors
Texas
$16.7M +$269K +2,272 +2%
Ameriprise
33
Ameriprise
Minnesota
$16M +$585K +4,937 +4%
CRCP
34
Copper Rock Capital Partners
Massachusetts
$14.6M +$4.58M +38,663 +43%
NFA
35
Nationwide Fund Advisors
Ohio
$14.1M +$2.9M +24,514 +25%
Millennium Management
36
Millennium Management
New York
$12.3M -$6.97M -58,806 -35%
VOYA Investment Management
37
VOYA Investment Management
Georgia
$12.1M -$18.5K -156 -0.1%
Geode Capital Management
38
Geode Capital Management
Massachusetts
$12.1M +$43.7K +369 +0.3%
RRAM
39
River Road Asset Management
Kentucky
$12.1M -$1.17M -9,902 -9%
First Trust Advisors
40
First Trust Advisors
Illinois
$10.4M +$1.86M +15,687 +21%
GI
41
GAMCO Investors
Connecticut
$10.2M -$391K -3,300 -4%
TCM
42
Tamarack Capital Management
California
$9.46M +$7.94M +67,009 +409%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$8.97M +$855K +7,215 +10%
SGA
44
Sector Gamma AS
Norway
$8.74M +$1.28M +10,800 +16%
Acadian Asset Management
45
Acadian Asset Management
Massachusetts
$8.53M +$6.9M +58,240 +344%
Renaissance Technologies
46
Renaissance Technologies
New York
$8.45M +$1.54M +13,000 +21%
TCIM
47
TIAA CREF Investment Management
New York
$7.68M -$42.8K -361 -0.5%
Morgan Stanley
48
Morgan Stanley
New York
$7.62M +$5.57K +47 +0.1%
EAM
49
Eagle Asset Management
Florida
$7.59M +$428K +3,616 +6%
TRSOTSOK
50
Teachers Retirement System of the State of Kentucky
Kentucky
$7.53M -$474K -4,000 -6%
1
2
3 4 5

BIO Hedge Fund Activity: Q3 2014 in Review

200 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q3 2014, worth a combined $2.1B — down 4.6% from $2.2B a quarter earlier.

Sellers outnumbered buyers: 22 funds closed out of BIO and 20 opened new positions — a net loss of 2 holders — while 72 trimmed existing stakes and 79 added.

The largest buyer was Epoch Investment Partners, opening a new position worth an estimated $22.3M. The largest seller was Norges Bank, cutting an estimated $18.3M.

  • 200 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q3 2014, down from 204 in Q2 2014.
  • Funds reported $2.1B of Bio-Rad Laboratories Class A stock for Q3 2014, down 4.6% quarter-over-quarter.
  • 20 funds opened new Bio-Rad Laboratories Class A positions in Q3 2014 and 22 closed out, a net change of -2 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q3 2014 was Epoch Investment Partners, an estimated $22.3M added.
  • The largest Bio-Rad Laboratories Class A seller in Q3 2014 was Norges Bank, an estimated $18.3M sold.

Based on aggregated 13F filings for Q3 2014.